A theme reflecting rising expectations for technological advances and commercialization across the iPS drug discovery and regenerative medicine sectors, against the backdrop of announcements by other companies and organizations regarding iPS drug discovery candidates, organ production, large-scale cell culture technologies and facility expansions.